Dose-Exploration Evaluating the Efficacy and Safety of Voclosporin in Subjects With Focal Segmental Glomerulosclerosis
Status:
Terminated
Trial end date:
2020-05-19
Target enrollment:
Participant gender:
Summary
Evaluating the Efficacy and Safety of Voclosporin in Achieving Complete or Partial Remission
of Proteinuria in Subjects with Focal Segmental Glomerulosclerosis